Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
Halozyme To Receive $15 Million Milestone Payment From Janssen
08:03pm, Thursday, 14'th May 2020Halozyme To Receive $15 Million Milestone Payment From Janssen
08:01pm, Thursday, 14'th May 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the company will receive a $15 million milestone payment from Janssen Biotech, Inc. (Janssen) triggered under the Collaboration and License A
Barclays Sticks to Their Hold Rating for Halozyme Therapeutics
07:18am, Wednesday, 13'th May 2020
Barclays (LON:BARC) analyst Gena Wang maintained a Hold rating on Halozyme (NASDAQ:HALO) Therapeutics on Tuesday, setting a price target of $21, which is approximately 15.39% below the present share p
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
JMP Securities Maintains Market Outperform on Halozyme Therapeutics, Raises Price Target to $34
03:31pm, Tuesday, 12'th May 2020JP Morgan Maintains Overweight on Halozyme Therapeutics, Raises Price Target to $23
02:43pm, Tuesday, 12'th May 2020BMO Capital Maintains Outperform on Halozyme Therapeutics, Raises Price Target to $35
02:36pm, Tuesday, 12'th May 2020Halozyme (HALO) Q1 Earnings and Revenues Miss Estimates
01:52pm, Tuesday, 12'th May 2020
Halozyme (HALO) reports wider-than-expected Q1 loss. Shares down.
Halozyme Therapeutics Inc (HALO) Q1 2020 Earnings Call Transcript
08:31am, Tuesday, 12'th May 2020
Leading the call will be Dr. Helen Torley, Halozyme's President and Chief Executive Officer, who will provide an update on our business and Elaine Sun, our Chief Financial Officer who will review our
Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q1 2020 Results - Earnings Call Transcript
01:27am, Tuesday, 12'th May 2020
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Al Kildani – Vice President-Investor Rel
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
Halozyme Therapeutics (HALO) Reports Q1 Loss, Lags Revenue Estimates
10:35pm, Monday, 11'th May 2020
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of -300.00% and -35.57%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stoc
